Önsel Öner1, Figen Deveci1, Selda Telo2, Mutlu Kuluöztürk1, Mehmet Balin3. 1. Firat University, School of Medicine, Department of Pulmonary Medicine, Elazig, Turkey. 2. Firat University, School of Medicine, Department of Biochemistry, Elazig, Turkey. 3. Firat University, School of Medicine, Department of Cardiology, Elazig, Turkey.
Abstract
BACKGROUND: The aim of this study was to determine levels of Mid-regional Pro-adrenomedullin (MR-proADM) and Mid-regional Pro-atrial Natriuretic Peptide (MR-proANP) in patients with acute pulmonary embolism (PE), the relationship between these parameters and the risk classification in addition to determining the relationship between 1and 3month mortality. METHODS: 82 PE patients and 50 healthy control subjects were included in the study. Blood samples for Mr-proANP and Mr-proADM were obtained from the subjects prior to the treatment. Risk stratification was determined according to sPESI (Simplified Pulmonary Embolism Severity Index). Following these initial measurements, cases with PE were assessed in terms of all causative and PE related mortalities. RESULTS: The mean serum Mr-proANP and Mr-proADM levels in acute PE patients were found to be statistically higher compared to the control group (p < 0.001, p < 0.01; respectively) and statistically significantly higher in high-risk patients than low-risk patients (p < 0.01, p < 0.05; respectively). No statistical difference was determined in high-risk patients in case of sPESI compared to low-risk patients while hospital mortality rates were higher. It was determined that the hospital mortality rate in cases with Mr-proANP ≥ 123.30 pmol/L and the total 3-month mortality rate in cases with Mr-proADM ≥ 152.2 pg/mL showed a statistically significant increase. CONCLUSIONS: This study showed that Mr-proANP and MRproADM may be an important biochemical marker for determining high-risk cases and predicting the mortality in PE patients and we believe that these results should be supported by further and extensive studies. 2020 Önsel Öner, Figen Deveci, Selda Telo, Mutlu Kuluöztürk, Mehmet Balin, published by CEON/CEES.
BACKGROUND: The aim of this study was to determine levels of Mid-regional Pro-adrenomedullin (MR-proADM) and Mid-regional Pro-atrial Natriuretic Peptide (MR-proANP) in patients with acute pulmonary embolism (PE), the relationship between these parameters and the risk classification in addition to determining the relationship between 1and 3month mortality. METHODS: 82 PE patients and 50 healthy control subjects were included in the study. Blood samples for Mr-proANP and Mr-proADM were obtained from the subjects prior to the treatment. Risk stratification was determined according to sPESI (Simplified Pulmonary Embolism Severity Index). Following these initial measurements, cases with PE were assessed in terms of all causative and PE related mortalities. RESULTS: The mean serum Mr-proANP and Mr-proADM levels in acute PE patients were found to be statistically higher compared to the control group (p < 0.001, p < 0.01; respectively) and statistically significantly higher in high-risk patients than low-risk patients (p < 0.01, p < 0.05; respectively). No statistical difference was determined in high-risk patients in case of sPESI compared to low-risk patients while hospital mortality rates were higher. It was determined that the hospital mortality rate in cases with Mr-proANP ≥ 123.30 pmol/L and the total 3-month mortality rate in cases with Mr-proADM ≥ 152.2 pg/mL showed a statistically significant increase. CONCLUSIONS: This study showed that Mr-proANP and MRproADM may be an important biochemical marker for determining high-risk cases and predicting the mortality in PE patients and we believe that these results should be supported by further and extensive studies. 2020 Önsel Öner, Figen Deveci, Selda Telo, Mutlu Kuluöztürk, Mehmet Balin, published by CEON/CEES.
Authors: Justyna Pedowska-Włoszek; Maciej Kostrubiec; Katarzyna Kurnicka; Michal Ciurzynski; Piotr Palczewski; Piotr Pruszczyk Journal: Thromb Res Date: 2013-08-19 Impact factor: 3.944
Authors: J Gustav Smith; Christopher Newton-Cheh; Bo Hedblad; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Thomas J Wang; Olle Melander Journal: Clin Chem Date: 2009-06-18 Impact factor: 8.327
Authors: Alan Maisel; Christian Mueller; Richard Nowak; W Frank Peacock; Judd W Landsberg; Piotr Ponikowski; Martin Mockel; Christopher Hogan; Alan H B Wu; Mark Richards; Paul Clopton; Gerasimos S Filippatos; Salvatore Di Somma; Inder Anand; Leong Ng; Lori B Daniels; Sean-Xavier Neath; Robert Christenson; Mihael Potocki; James McCord; Garret Terracciano; Dimitrios Kremastinos; Oliver Hartmann; Stephan von Haehling; Andreas Bergmann; Nils G Morgenthaler; Stefan D Anker Journal: J Am Coll Cardiol Date: 2010-05-11 Impact factor: 24.094
Authors: Alan Maisel; Christian Mueller; Richard M Nowak; W Frank Peacock; Piotr Ponikowski; Martin Mockel; Christopher Hogan; Alan H B Wu; Mark Richards; Paul Clopton; Gerasimos S Filippatos; Salvatore Di Somma; Inder Anand; Leong L Ng; Lori B Daniels; Sean-Xavier Neath; Robert Christenson; Mihael Potocki; James McCord; Oliver Hartmann; Nils G Morgenthaler; Stefan D Anker Journal: J Am Coll Cardiol Date: 2011-08-30 Impact factor: 24.094
Authors: Eva Grolimund; Alexander Kutz; Robert J Marlowe; Alaadin Vögeli; Murat Alan; Mirjam Christ-Crain; Robert Thomann; Claudine Falconnier; Claus Hoess; Christoph Henzen; Werner Zimmerli; Beat Mueller; Philipp Schuetz Journal: COPD Date: 2014-09-17 Impact factor: 2.409
Authors: Rafael Golpe; Luis A Pérez-de-Llano; Olalla Castro-Añón; Manuel Vázquez-Caruncho; Carlos González-Juanatey; Alejandro Veres-Racamonde; Concepción Iglesias-Moreira; María Carmen Fariñas Journal: Respir Med Date: 2010-04-24 Impact factor: 3.415
Authors: Daiana Stolz; Mirjam Christ-Crain; Nils G Morgenthaler; David Miedinger; Jörg Leuppi; Christian Müller; Roland Bingisser; Joachim Struck; Beat Müller; Michael Tamm Journal: Chest Date: 2008-05-19 Impact factor: 9.410
Authors: C D Vizza; C Letizia; S Sciomer; R Naeije; G Della Rocca; A Di Roma; S Musarò; S Quattrucci; C Gaudio; A Battagliese; R Badagliacca; E D'Erasmo; F Fedele Journal: Regul Pept Date: 2005-01-15
Authors: Stavros V Konstantinides; Guy Meyer; Cecilia Becattini; Héctor Bueno; Geert-Jan Geersing; Veli-Pekka Harjola; Menno V Huisman; Marc Humbert; Catriona Sian Jennings; David Jiménez; Nils Kucher; Irene Marthe Lang; Mareike Lankeit; Roberto Lorusso; Lucia Mazzolai; Nicolas Meneveau; Fionnuala Ní Áinle; Paolo Prandoni; Piotr Pruszczyk; Marc Righini; Adam Torbicki; Eric Van Belle; José Luis Zamorano Journal: Eur Heart J Date: 2020-01-21 Impact factor: 35.855